[1] Siew ZY, Loh A, Segeran S, et al. Oncolytic reoviruses: can these emerging zoonotic reoviruses be tamed and utilized? DNA Cell Biol, 2023; 42, 289−304.
[2] Tee KK, Chan PQ, Loh AMK, et al. Surveillance, isolation and genomic characterization of Pteropine orthoreovirus of probable bat origin among patients with acute respiratory infection in Malaysia. J Med Virol, 2023; 95, e28520. doi:  10.1002/jmv.28520
[3] Egawa K, Shimojima M, Taniguchi S, et al. Virulence, pathology, and pathogenesis of Pteropine orthoreovirus (PRV) in BALB/c mice: development of an animal infection model for PRV. PLoS Negl Trop Dis, 2017; 11, e0006076. doi:  10.1371/journal.pntd.0006076
[4] Tarigan R, Katta T, Takemae H, et al. Distinct interferon response in bat and other mammalian cell lines infected with Pteropine orthoreovirus. Virus Genes, 2021; 57, 510−20. doi:  10.1007/s11262-021-01865-6
[5] Loh A, Shaibie NA, Chan PQ, et al. Pteropine orthoreovirus, PRV7S (Sikamat Virus) demonstrates oncolysis in nasopharyngeal carcinoma cell lines. Front Biosci, 2022; 27, 138. doi:  10.31083/j.fbl2704138
[6] Hamamdzic D, Phillips-Dorsett T, Altman-Hamamdzic S, et al. Reovirus triggers cell type-specific proinflammatory responses dependent on the autocrine action of IFN-β. Am J Physiol Lung Cell Mol Physiol, 2001; 280, L18−29. doi:  10.1152/ajplung.2001.280.1.L18
[7] Phillips MB, Stuart JD, Rodríguez Stewart RM, et al. Current understanding of reovirus oncolysis mechanisms. Oncolytic Virother, 2018; 7, 53−63. doi:  10.2147/OV.S143808
[8] Clements D, Helson E, Gujar SA, et al. Reovirus in cancer therapy: an evidence-based review. Oncolytic Virother, 2014; 3, 69−82.
[9] Steele L, Errington F, Prestwich R, et al. Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Mol Cancer, 2011; 10, 20. doi:  10.1186/1476-4598-10-20
[10] Mohamed A, Konda P, Eaton HE, et al. Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus -independent host genes, via mechanisms of slow replication versus polymorphisms in dsRNA binding σ3 respectively. PLoS Pathog, 2020; 16, e1008803. doi:  10.1371/journal.ppat.1008803
[11] Alcami A. Viral anticytokine strategies. Encycl Immunobiol, 2016; 2, 597−604.
[12] Prestwich RJ, Errington F, Steele LP, et al. Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus. J Immunol, 2009; 183, 4312−21. doi:  10.4049/jimmunol.0901074
[13] Xiao YY, Li SY, Su Q, et al. 81. Downregulation of immune responsive chemokines are associated AAV8-mediated transgene immune tolerance. Mol Ther, 2016; 24, S35−6.